The Week2d
Carving a niche in biotechnology with BioE3 Policy
The research got the thrust after the Department of Biotechnology (DBT), Ministry of Science and Technology and Indian Space ...
CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today ...
Business Matters18h
Leen Kawas on Resilience as Strategy: The Role of Female Leadership in Transformative Change
Leen Kawas, a biotech industry leader, details the importance of resilience for female innovators across any industry.
BriaCell Therapeutics Announces Closing of Public Offering
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” ...
Leerink Partnrs Has Pessimistic View of IRWD Q1 Earnings
Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for Ironwood Pharmaceuticals in a research report issued on Wednesday, January 29th. Leerink Partnrs analyst F. Khurshid now ...
SG Americas Securities LLC Buys 48,793 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
SG Americas Securities LLC grew its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 796.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 54,921 shares of the ...
CytoDyn Inc.: CytoDyn Announces Findings of Statistically Significant Fibrosis Reversal Across Studies with SMC Laboratories
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...
TMCnet2d
Quince Therapeutics Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia
Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...
Diagen Ai Inc. Announces The Addition Of Ali Urman To Lead Its Advisory Board And Participation In Upcoming Conferences
Brian D. Keane Diagen Ai Inc. +1 201-736-3590 ... Visit us on social media: X LinkedIn Instagram ...
Apogee Therapeutics Announces First Patient Dosed in Part B of Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis
Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolledPart A 16-week proof-of-concept data ...
BriaCell announces public offering of common shares
PHILADELPHIA and VANCOUVER, British Columbia - BriaCell Therapeutics Corp., a clinical-stage biotechnology company specializing in immunotherapies for cancer care, announced today its plans to conduct ...
SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico
The patent refers to SciSparc’s innovative combination therapy of N-Acylethanolamines and Clearmind’s MEAI, (5-methoxy-2-aminoindane) addressing binge behaviour, including alcohol consumption, eating, ...